Given the growing importance of immunotherapy in lung cancer treatment, further investigation into TBRG4’s role in immune checkpoint regulation and its interaction with the tumor immune microenvironment could uncover novel therapeutic strategies. The gene discussed is TBRG4; the disease is neoplasm.